TrialPloS one2013

Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51.

Chengzhi Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.